GOPC: ROS1 and other ROS1 fusions represent a rare but recurrent drug target in a variety of glioma types - Sievers, Philipp; Stichel, Damian; Sill, Martin; Schrimpf, Daniel; Sturm, Dominik; Selt, Florian; Ecker, Jonas; Kazdal, Daniel; Miele, Evelina; Kranendonk, Mariëtte E. G.; Tops, Bastiaan B. J.; Kohlhof-Meinecke, Patricia; et al. (Acta neuropathologica, 2021)
Gesehen am 04.08.2023